Stockscreener 앱 받기
2.14
3.39%
-0.07
Invivyd Inc 주식(IVVD)의 최신 뉴스
H.C. Wainwright reaffirms Buy rating on Invivyd stock ahead of key trial data - Investing.com
Analysts Are Bullish on These Healthcare Stocks: Invivyd (IVVD), Alignment Healthcare (ALHC) - The Globe and Mail
Invivyd partners with ski champion Lindsey Vonn on antibody education By Investing.com - Investing.com Nigeria
Invivyd prices $125M stock offering at $2.50 per share - MSN
Invivyd, Inc. (IVVD) Reports Q1 Loss, Lags Revenue Estimates - sharewise.com
Invivyd partners with ski champion Lindsey Vonn on antibody education - Investing.com
Invivyd stock rises after partnering with Olympic champion Lindsey Vonn By Investing.com - Investing.com Canada
Invivyd partners with Lindsey Vonn to educate Americans on antibodies and disease prevention - marketscreener.com
Lindsey Vonn joins Invivyd to help Americans understand antibodies - Stock Titan
Invivyd stock maintains Buy rating at BTIG on Long COVID treatment potential By Investing.com - Investing.com Nigeria
Invivyd stock maintains Buy rating at BTIG on Long COVID treatment potential - Investing.com Nigeria
Invivyd to begin phase 2 trial of antibody therapy for long COVID - Investing.com Nigeria
Invivyd and SPEAR Study Group Announce Plan for Phase 2 Study of VYD2311 for Treatment of Long COVID and COVID Vaccine-Injured Individuals to Commence Mid-2026 - The Manila Times
Invivyd Initiates Phase 2 Trial for VYD2311 Targeting Long COVID Patients - Intellectia AI
Experimental COVID antibody trial targets Long COVID and vaccine injury by 2026 - Stock Titan
Short Interest in Invivyd, Inc. (NASDAQ:IVVD) Grows By 24.4% - MarketBeat
Bull Run: What is the target price for Invivyd Inc stockMarket Volume Summary & Safe Entry Trade Reports - baoquankhu1.vn
Invivyd, Inc.'s (NASDAQ:IVVD) Business Is Trailing The Industry But Its Shares Aren't - 富途资讯
Invivyd, Inc. (NASDAQ:IVVD) Given Average Rating of "Hold" by Brokerages - MarketBeat
Invivyd (IVVD) Reports Strong Q4 Growth, Advances COVID Antibody to Phase 3 - Insider Monkey
10 Best Penny Stocks to Buy for 2026 - Insider Monkey
MINISTRY OF HOME AFFAIRS OF THE SOCIALIST REPUBLIC OF VIETNAM - Bộ Nội Vụ
Invivyd (NASDAQ:IVVD) Trading Down 6.5%Time to Sell? - MarketBeat
Invivyd granted FDA fast track status for COVID therapy - MSN
Why Analysts See Invivyd (IVVD) Story Shifting After REVOLUTION Program And US$10 Target - Yahoo Finance
Invivyd (NASDAQ:IVVD) Trading Up 10.6%What's Next? - MarketBeat
Invivyd reports 25% growth in Q4 PEMGARDA revenue to $17.2 million - Investing.com Nigeria
Will Invivyd's DECLARATION Trial Send IVVD Stock Higher In 2026? - RTTNews
Invivyd (NASDAQ:IVVD) Shares Gap UpWhat's Next? - MarketBeat
Why Invivyd Inc. stock is trending among retail traders2025 Earnings Surprises & Free Reliable Trade Execution Plans - ulpravda.ru
Invivyd Reports Strong PEMGARDA Growth and Advances VYD2311 - TipRanks
Invivyd, Inc. Reports Preliminary Q4 2025 Revenue of $17.2 Million and Announces Key Clinical Developments - Quiver Quantitative
Invivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights - The Manila Times
Star TribuneInvivyd Reports Preliminary Fourth Quarter 2025 Revenue and Recent Business Highlights - FinancialContent
Invivyd, Inc. (IVVD): Advancing RSV antibody VBY329 amid analyst downgrade - MSN
Invivyd (NASDAQ:IVVD) Stock Price Down 5.5%Here's What Happened - MarketBeat
Aug Gainers: Why Heiwa Real Estate Co Ltd HZJ stock appears on watchlistsDividend Hike & Growth Focused Entry Reports - moha.gov.vn
Invivyd Inc. | Latest News & Innovations - shababeek.org
BTIG initiates Invivyd (IVVD) coverage, cites VYD2311’s superior market potential over Pemgarda - MSN
BTIG Initiates Invivyd (IVVD) Coverage, Cites VYD2311’s Superior Market Potential Over Pemgarda - Insider Monkey
Invivyd (NASDAQ:IVVD) Trading Down 3.7%Here's Why - MarketBeat
Is Invivyd Inc. stock supported by strong fundamentalsChart Pattern Recognition & Minimal Risk High Reward - bollywoodhelpline.com
Does Invivyd’s (IVVD) Index Debut Reveal a Turning Point in Its Biotech Credibility? - Yahoo Finance
BTIG Reiterates Invivyd (IVVD) Buy Recommendation - Nasdaq
BTIG Research Upgrades Invivyd (NASDAQ:IVVD) to Strong-Buy - MarketBeat
FDA grants fast track designation for Invivyd’s COVID antibody By Investing.com - Investing.com Nigeria
Invivyd begins phase 3 trial of COVID prevention antibody VYD2311 By Investing.com - Investing.com Nigeria
US OPEN: Markets wobble amid low volumes and resilient GDP (23.12.2025) - XTB.com
Is Invivyd’s (IVVD) Index Debut Quietly Reframing Its Long-Term Biotech Positioning? - simplywall.st
Invivyd wins FDA fast track tag for COVID drug (IVVD:NASDAQ) - Seeking Alpha
3.27%
2.09%
자본화:
|
볼륨(24시간):